Ghost Tree Capital’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-575,000
Closed -$20.4M 58
2020
Q2
$20.4M Sell
575,000
-475,000
-45% -$13.9M 5.38% 2
2020
Q1
$14.2M Buy
1,050,000
+550,000
+110% +$9.25M 3.75% 7
2019
Q4
$10.6M Sell
500,000
-225,000
-31% -$3.97M 2.01% 17
2019
Q3
$9.61M Buy
725,000
+125,000
+21% +$1.84M 2.45% 16
2019
Q2
$8.32M Sell
600,000
-200,000
-25% -$3.01M 1.73% 17
2019
Q1
$15.4M Hold
800,000
4.02% 7
2018
Q4
$11.4M Sell
800,000
-83,823
-9% -$1.66M 4.14% 5
2018
Q3
$18.4M Sell
883,823
-366,177
-29% -$8.67M 3.91% 6
2018
Q2
$29.6M Sell
1,250,000
-600,000
-32% -$12.1M 8.71% 1
2018
Q1
$27M Buy
1,850,000
+312,000
+20% +$5.1M 5.47% 3
2017
Q4
$24.9M Sell
1,538,000
-408,946
-21% -$4.83M 5.83% 2
2017
Q3
$27.2M Buy
1,946,946
+746,946
+62% +$7.44M 5.78% 2
2017
Q2
$10.6M Sell
1,200,000
-300,000
-20% -$2.11M 2.2% 14
2017
Q1
$9.71M Sell
1,500,000
-200,000
-12% -$1.01M 1.81% 18
2016
Q4
$6.24M Sell
1,700,000
-300,000
-15% -$888K 1.5% 28
2016
Q3
$6.5M Buy
2,000,000
+1,000,000
+100% +$2.8M 1.05% 35
2016
Q2
$2.32M Buy
+1,000,000
New +$3.34M 0.67% 43

Other funds holding IMMU

Ghost Tree Capital's IMMU Position: Q3 2020 in Review

Ghost Tree Capital sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 575,000 shares — an estimated $20.4M sold.

Ghost Tree Capital first reported a position in IMMU in Q2 2016 and held it in 17 quarters. The position peaked at $29.6M in Q2 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Ghost Tree Capital reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Ghost Tree Capital sold 575,000 Immunomedics Inc shares in Q3 2020, an estimated $20.4M.
  • Ghost Tree Capital first reported a position in Immunomedics Inc in Q2 2016 and held it in 17 quarters.
  • Ghost Tree Capital's Immunomedics Inc position peaked at $29.6M in Q2 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Ghost Tree Capital's 13F filing for Q3 2020, filed 16 Nov 2020.